Christina Farr

Author of Second Opinion, a health-technology newsletter with more than 20,000 subscribers. Former journalist with CNBC, Fast company and Reuters, and VC with OMERS Ventures.

Sep 05, 2024

We're undervaluing the importance of community in digital health

Build for the needs of a community, not a single condition

Christina Farr

Aug 29, 2024

Where we see opportunities at the intersection of fin-tech and health-tech

RCM, transparency tools, HSA/FSAs and more

Christina Farr, +1

Aug 22, 2024

An OB Gyn's view of the menopause market

Not all companies (or hormones) are created equal

Christina Farr

Aug 15, 2024

The case for the physical clinic

In this market, we're undervaluing and underestimating brick and mortar

Christina Farr, +2

Jul 31, 2024

A few unfiltered thoughts on Flo, the $1 billion period-tracking app

The valuation may seem crazy, but it's actually not...

Christina Farr

Jul 26, 2024

A top endocrinologist reflects on what he got wrong about the future of diabetes care

We return to a bold 2019 prediction from Dr. Aaron Neinstein, plus a review of Ezra's Whole Body MRI

Christina Farr

Jul 18, 2024

Point Solution fatigue is very real

So where do we go from here?

Christina Farr

Jul 11, 2024

Your guide to how policymakers are regulating AI in healthcare

We’ve compiled all the major U.S. laws and policies so you don't have to

Christina Farr, +1

Jul 05, 2024

I'm launching a Second Opinion "authors" program

Reach out if that's you!

Christina Farr

Jul 01, 2024

We are having an impact

Let's go

Christina Farr